4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sirnaomics Ltd. (2257) operates in the Biotechnology industry and is headquartered in Germantown, United States with about 37 employees. Its market capitalization is roughly $435 million. In the fiscal year ended 2025-12-31, 2257 reported $0M in revenue and ($14M) in net income.
Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People's Republic of China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $2M | $0M | $0M | — |
| Gross Profit | $0M | $1M | $0M | — | — |
| Operating Income (EBIT) | ($15M) | ($36M) | ($77M) | ($91M) | — |
| Net Income | ($14M) | ($51M) | ($79M) | ($88M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $21M | $28M | $76M | $164M | — |
| Total Liabilities | $45M | $44M | $51M | $52M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2257 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms